APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Schistosomiasis

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Selected research

Industry Growth & Trends

Global Drugs for Schistosomiasis Industry Growth and Trends Forecast to 2032

25 December 202599 pages

Choose your research edition.

Industry ResearchDrugs for Schistosomiasis Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Schistosomiasis Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Drugs for Schistosomiasis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Schistosomiasis Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Schistosomiasis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.

East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,

Read the full market overview

Followed by West Africa(20%).

Report Scope

This report provides a structured, data-driven view of the global Drugs for Schistosomiasis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Schistosomiasis market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Schistosomiasis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Schistosomiasis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drugs for Schistosomiasis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Schistosomiasis Market by Company

Shin Poong

Merck

Bayer

EIPICO

Chandra Bhagat Pharma

Taj Pharmaceuticals

Drugs for Schistosomiasis Segment by Type

Praziquantel

Oxamniquine

Other

Drugs for Schistosomiasis Segment by Application

S. haematobium

S. mansoni

S. japonicum

S. mekongi

S. intercalatum

Drugs for Schistosomiasis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Schistosomiasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Schistosomiasis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Schistosomiasis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drugs for Schistosomiasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Praziquantel Table 2. Major Company of Oxamniquine Table 3. Major Company of Other Table 4. Global Drugs for Schistosomiasis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 6. Global Drugs for Schistosomiasis Sales Market Share in Volume by Type (2021-2026) Table 7. Global Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 8. Global Drugs for Schistosomiasis Sales Market Share in Value by Type (2021-2026) Table 9. Global Drugs for Schistosomiasis Price by Type (2021-2026) & (USD/K Units) Table 10. Global Drugs for Schistosomiasis Sales by Type (2027-2032) & (M Units) Table 11. Global Drugs for Schistosomiasis Sales Market Share in Volume by Type (2027-2032) Table 12. Global Drugs for Schistosomiasis Sales by Type (2027-2032) & (US$ Million) Table 13. Global Drugs for Schistosomiasis Sales Market Share in Value by Type (2027-2032) Table 14. Global Drugs for Schistosomiasis Price by Type (2027-2032) & (USD/K Units) Table 15. North America Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 16. North America Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 18. Europe Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 22. Latin America Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2021-2026) & (US$ Million) Table 25. Drugs for Schistosomiasis Industry Trends Table 26. Drugs for Schistosomiasis Industry Drivers Table 27. Drugs for Schistosomiasis Industry Opportunities and Challenges Table 28. Drugs for Schistosomiasis Industry Restraints Table 29. Global Drugs for Schistosomiasis Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Drugs for Schistosomiasis Revenue Market Share by Company (2021-2026) Table 31. Global Drugs for Schistosomiasis Sales by Company (2021-2026) & (M Units) Table 32. Global Drugs for Schistosomiasis Sales Share by Company (2021-2026) Table 33. Global Drugs for Schistosomiasis Market Price by Company (2021-2026) & (USD/K Units) Table 34. Global Drugs for Schistosomiasis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Drugs for Schistosomiasis Major Company Production Sites and Headquarters Table 36. Global Drugs for Schistosomiasis Company, Product Type & Application Table 37. Global Drugs for Schistosomiasis Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Drugs for Schistosomiasis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Drugs for Schistosomiasis Sales by Region (2021-2026) & (M Units) Table 42. Global Drugs for Schistosomiasis Sales Market Share in Volume by Region (2021-2026) Table 43. Global Drugs for Schistosomiasis Sales by Region (2021-2026) & (US$ Million) Table 44. Global Drugs for Schistosomiasis Sales Market Share in Value by Region (2021-2026) Table 45. Global Drugs for Schistosomiasis Sales (M Units), Value (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 46. Global Drugs for Schistosomiasis Sales by Region (2027-2032) & (M Units) Table 47. Global Drugs for Schistosomiasis Sales Market Share in Volume by Region (2027-2032) Table 48. Global Drugs for Schistosomiasis Sales by Region (2027-2032) & (US$ Million) Table 49. Global Drugs for Schistosomiasis Sales Market Share in Value by Region (2027-2032) Table 50. Global Drugs for Schistosomiasis Sales (M Units), Value (US$ Million), Price (USD/K Units) and Gross Margin (2027-2032) Table 51. Global Drugs for Schistosomiasis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 53. Global Drugs for Schistosomiasis Sales Market Share in Volume by Application (2021-2026) Table 54. Global Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 55. Global Drugs for Schistosomiasis Sales Market Share in Value by Application (2021-2026) Table 56. Global Drugs for Schistosomiasis Price by Application (2021-2026) & (USD/K Units) Table 57. Global Drugs for Schistosomiasis Sales by Application (2027-2032) & (M Units) Table 58. Global Drugs for Schistosomiasis Sales Market Share in Volume by Application (2027-2032) Table 59. Global Drugs for Schistosomiasis Sales by Application (2027-2032) & (US$ Million) Table 60. Global Drugs for Schistosomiasis Sales Market Share in Value by Application (2027-2032) Table 61. Global Drugs for Schistosomiasis Price by Application (2027-2032) & (USD/K Units) Table 62. North America Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 63. North America Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 65. Europe Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 69. Latin America Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2021-2026) & (US$ Million) Table 72. Shin Poong Company Information Table 73. Shin Poong Business Overview Table 74. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 75. Shin Poong Drugs for Schistosomiasis Product Portfolio Table 76. Shin Poong Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 80. Merck Drugs for Schistosomiasis Product Portfolio Table 81. Merck Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 85. Bayer Drugs for Schistosomiasis Product Portfolio Table 86. Bayer Recent Development Table 87. EIPICO Company Information Table 88. EIPICO Business Overview Table 89. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 90. EIPICO Drugs for Schistosomiasis Product Portfolio Table 91. EIPICO Recent Development Table 92. Chandra Bhagat Pharma Company Information Table 93. Chandra Bhagat Pharma Business Overview Table 94. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 95. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio Table 96. Chandra Bhagat Pharma Recent Development Table 97. Taj Pharmaceuticals Company Information Table 98. Taj Pharmaceuticals Business Overview Table 99. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 100. Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio Table 101. Taj Pharmaceuticals Recent Development Table 102. North America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 103. North America Drugs for Schistosomiasis Sales by Country (2021-2026) & (M Units) Table 104. North America Drugs for Schistosomiasis Sales Market Share by Country (2021-2026) Table 105. North America Drugs for Schistosomiasis Sales Forecast by Country (2027-2032) & (M Units) Table 106. North America Drugs for Schistosomiasis Sales Market Share Forecast by Country (2027-2032) Table 107. North America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Drugs for Schistosomiasis Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Drugs for Schistosomiasis Market Share by Country (2021-2026) Table 110. North America Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Drugs for Schistosomiasis Market Share Forecast by Country (2027-2032) Table 112. Europe Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 113. Europe Drugs for Schistosomiasis Sales by Country (2021-2026) & (M Units) Table 114. Europe Drugs for Schistosomiasis Sales Market Share by Country (2021-2026) Table 115. Europe Drugs for Schistosomiasis Sales Forecast by Country (2027-2032) & (M Units) Table 116. Europe Drugs for Schistosomiasis Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Drugs for Schistosomiasis Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Drugs for Schistosomiasis Market Share by Country (2021-2026) Table 120. Europe Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Drugs for Schistosomiasis Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Drugs for Schistosomiasis Sales by Country (2021-2026) & (M Units) Table 124. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Drugs for Schistosomiasis Sales Forecast by Country (2027-2032) & (M Units) Table 126. Asia-Pacific Drugs for Schistosomiasis Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Drugs for Schistosomiasis Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Drugs for Schistosomiasis Market Share by Country (2021-2026) Table 130. Asia-Pacific Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Drugs for Schistosomiasis Market Share Forecast by Country (2027-2032) Table 132. Latin America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 133. Latin America Drugs for Schistosomiasis Sales by Country (2021-2026) & (M Units) Table 134. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2021-2026) Table 135. Latin America Drugs for Schistosomiasis Sales Forecast by Country (2027-2032) & (M Units) Table 136. Latin America Drugs for Schistosomiasis Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Drugs for Schistosomiasis Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Drugs for Schistosomiasis Market Share by Country (2021-2026) Table 140. Latin America Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Drugs for Schistosomiasis Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2021-2026) & (M Units) Table 144. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Drugs for Schistosomiasis Sales Forecast by Country (2027-2032) & (M Units) Table 146. Middle East and Africa Drugs for Schistosomiasis Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Drugs for Schistosomiasis Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Drugs for Schistosomiasis Market Share by Country (2021-2026) Table 150. Middle East and Africa Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Drugs for Schistosomiasis Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Drugs for Schistosomiasis Distributors List Table 155. Drugs for Schistosomiasis Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Drugs for Schistosomiasis Image Figure 2. Global Drugs for Schistosomiasis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for Schistosomiasis Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs for Schistosomiasis Sales (2021-2032) & (M Units) Figure 5. Praziquantel Image Figure 6. Global Praziquantel Sales YoY Growth (2021-2032) & (M Units) Figure 7. Oxamniquine Image Figure 8. Global Oxamniquine Sales YoY Growth (2021-2032) & (M Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Drugs for Schistosomiasis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Drugs for Schistosomiasis Market Share by Type 2025 VS 2032 Figure 13. North America Drugs for Schistosomiasis Sales Market Share in Volume by Type in 2025 Figure 14. North America Drugs for Schistosomiasis Sales Market Share in Value by Type in 2025 Figure 15. Europe Drugs for Schistosomiasis Sales Market Share in Volume by Type in 2025 Figure 16. Europe Drugs for Schistosomiasis Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Drugs for Schistosomiasis Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Drugs for Schistosomiasis Sales Market Share in Value by Type in 2025 Figure 19. Latin America Drugs for Schistosomiasis Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Drugs for Schistosomiasis Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Drugs for Schistosomiasis Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Drugs for Schistosomiasis Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Drugs for Schistosomiasis Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. S. haematobium Image Figure 26. Global S. haematobium Sales YoY Growth (2021-2032) & (M Units) Figure 27. S. mansoni Image Figure 28. Global S. mansoni Sales YoY Growth (2021-2032) & (M Units) Figure 29. S. japonicum Image Figure 30. Global S. japonicum Sales YoY Growth (2021-2032) & (M Units) Figure 31. S. mekongi Image Figure 32. Global S. mekongi Sales YoY Growth (2021-2032) & (M Units) Figure 33. S. intercalatum Image Figure 34. Global S. intercalatum Sales YoY Growth (2021-2032) & (M Units) Figure 35. Global Drugs for Schistosomiasis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Drugs for Schistosomiasis Market Share by Application 2025 VS 2032 Figure 37. North America Drugs for Schistosomiasis Sales Market Share in Volume by Application in 2025 Figure 38. North America Drugs for Schistosomiasis Sales Market Share in Value by Application in 2025 Figure 39. Europe Drugs for Schistosomiasis Sales Market Share in Volume by Application in 2025 Figure 40. Europe Drugs for Schistosomiasis Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Drugs for Schistosomiasis Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Drugs for Schistosomiasis Sales Market Share in Value by Application in 2025 Figure 43. Latin America Drugs for Schistosomiasis Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Drugs for Schistosomiasis Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Drugs for Schistosomiasis Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Drugs for Schistosomiasis Sales Market Share in Value by Application in 2025 Figure 47. North America Drugs for Schistosomiasis Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. North America Drugs for Schistosomiasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Drugs for Schistosomiasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Drugs for Schistosomiasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Drugs for Schistosomiasis Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Europe Drugs for Schistosomiasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Drugs for Schistosomiasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Drugs for Schistosomiasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Drugs for Schistosomiasis Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Asia-Pacific Drugs for Schistosomiasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Drugs for Schistosomiasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Drugs for Schistosomiasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Drugs for Schistosomiasis Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Latin America Drugs for Schistosomiasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Drugs for Schistosomiasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Drugs for Schistosomiasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Drugs for Schistosomiasis Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 64. Middle East and Africa Drugs for Schistosomiasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Drugs for Schistosomiasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Drugs for Schistosomiasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Drugs for Schistosomiasis Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Drugs for Schistosomiasis Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Praziquantel
  • Oxamniquine
  • Other
Applications
  • S. haematobium
  • S. mansoni
  • S. japonicum
  • S. mekongi
  • S. intercalatum
Companies covered
  • Shin Poong
  • Merck
  • Bayer
  • EIPICO
  • Chandra Bhagat Pharma
  • Taj Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drugs for Schistosomiasis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drugs for Schistosomiasis Market by Type
  6. 1.3.1 Praziquantel
  7. 1.3.2 Oxamniquine
  8. 1.3.3 Other
  9. 1.4 Global Drugs for Schistosomiasis Market Size by Type
  10. 1.4.1 Global Drugs for Schistosomiasis Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Drugs for Schistosomiasis Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Drugs for Schistosomiasis Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Drugs for Schistosomiasis Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Drugs for Schistosomiasis Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Drugs for Schistosomiasis Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Drugs for Schistosomiasis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drugs for Schistosomiasis Industry Trends
  2. 2.2 Drugs for Schistosomiasis Industry Drivers
  3. 2.3 Drugs for Schistosomiasis Industry Opportunities and Challenges
  4. 2.4 Drugs for Schistosomiasis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drugs for Schistosomiasis Revenue (2021-2026)
  2. 3.2 Global Top Players by Drugs for Schistosomiasis Sales (2021-2026)
  3. 3.3 Global Top Players by Drugs for Schistosomiasis Price (2021-2026)
  4. 3.4 Global Drugs for Schistosomiasis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs for Schistosomiasis Major Company Production Sites & Headquarters
  6. 3.6 Global Drugs for Schistosomiasis Company, Product Type & Application
  7. 3.7 Global Drugs for Schistosomiasis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs for Schistosomiasis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs for Schistosomiasis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs for Schistosomiasis Tier 1, Tier 2, and Tier 3
4 Drugs for Schistosomiasis Regional Status and Outlook
  1. 4.1 Global Drugs for Schistosomiasis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drugs for Schistosomiasis Historic Market Size by Region
  3. 4.2.1 Global Drugs for Schistosomiasis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drugs for Schistosomiasis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drugs for Schistosomiasis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drugs for Schistosomiasis Forecasted Market Size by Region
  7. 4.3.1 Global Drugs for Schistosomiasis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drugs for Schistosomiasis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drugs for Schistosomiasis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs for Schistosomiasis by Application
  1. 5.1 Drugs for Schistosomiasis Market by Application
  2. 5.1.1 S. haematobium
  3. 5.1.2 S. mansoni
  4. 5.1.3 S. japonicum
  5. 5.1.4 S. mekongi
  6. 5.1.5 S. intercalatum
  7. 5.2 Global Drugs for Schistosomiasis Market Size by Application
  8. 5.2.1 Global Drugs for Schistosomiasis Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Drugs for Schistosomiasis Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Drugs for Schistosomiasis Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Drugs for Schistosomiasis Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Drugs for Schistosomiasis Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Drugs for Schistosomiasis Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Drugs for Schistosomiasis Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Drugs for Schistosomiasis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shin Poong
  2. 6.1.1 Shin Poong Company Information
  3. 6.1.2 Shin Poong Business Overview
  4. 6.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shin Poong Drugs for Schistosomiasis Product Portfolio
  6. 6.1.5 Shin Poong Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Drugs for Schistosomiasis Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Drugs for Schistosomiasis Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 EIPICO
  20. 6.4.1 EIPICO Company Information
  21. 6.4.2 EIPICO Business Overview
  22. 6.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 EIPICO Drugs for Schistosomiasis Product Portfolio
  24. 6.4.5 EIPICO Recent Developments
  25. 6.5 Chandra Bhagat Pharma
  26. 6.5.1 Chandra Bhagat Pharma Company Information
  27. 6.5.2 Chandra Bhagat Pharma Business Overview
  28. 6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
  30. 6.5.5 Chandra Bhagat Pharma Recent Developments
  31. 6.6 Taj Pharmaceuticals
  32. 6.6.1 Taj Pharmaceuticals Company Information
  33. 6.6.2 Taj Pharmaceuticals Business Overview
  34. 6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
  36. 6.6.5 Taj Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Drugs for Schistosomiasis Sales by Country
  2. 7.1.1 North America Drugs for Schistosomiasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drugs for Schistosomiasis Sales by Country (2021-2026)
  4. 7.1.3 North America Drugs for Schistosomiasis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drugs for Schistosomiasis Market Size by Country
  6. 7.2.1 North America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drugs for Schistosomiasis Market Size by Country (2021-2026)
  8. 7.2.3 North America Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drugs for Schistosomiasis Sales by Country
  2. 8.1.1 Europe Drugs for Schistosomiasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drugs for Schistosomiasis Sales by Country (2021-2026)
  4. 8.1.3 Europe Drugs for Schistosomiasis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drugs for Schistosomiasis Market Size by Country
  6. 8.2.1 Europe Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drugs for Schistosomiasis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drugs for Schistosomiasis Sales by Country
  2. 9.1.1 Asia-Pacific Drugs for Schistosomiasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drugs for Schistosomiasis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drugs for Schistosomiasis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drugs for Schistosomiasis Market Size by Country
  6. 9.2.1 Asia-Pacific Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drugs for Schistosomiasis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drugs for Schistosomiasis Sales by Country
  2. 10.1.1 South America Drugs for Schistosomiasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drugs for Schistosomiasis Sales by Country (2021-2026)
  4. 10.1.3 South America Drugs for Schistosomiasis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drugs for Schistosomiasis Market Size by Country
  6. 10.2.1 South America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drugs for Schistosomiasis Market Size by Country (2021-2026)
  8. 10.2.3 South America Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country
  2. 11.1.1 Middle East and Africa Drugs for Schistosomiasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drugs for Schistosomiasis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drugs for Schistosomiasis Market Size by Country
  6. 11.2.1 Middle East and Africa Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drugs for Schistosomiasis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drugs for Schistosomiasis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drugs for Schistosomiasis Value Chain Analysis
  2. 12.1.1 Drugs for Schistosomiasis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drugs for Schistosomiasis Production Mode & Process
  7. 12.2 Drugs for Schistosomiasis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drugs for Schistosomiasis Distributors
  10. 12.2.3 Drugs for Schistosomiasis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst